These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
167 related articles for article (PubMed ID: 39227956)
21. Effectiveness of five artemisinin combination regimens with or without primaquine in uncomplicated falciparum malaria: an open-label randomised trial. Smithuis F; Kyaw MK; Phe O; Win T; Aung PP; Oo AP; Naing AL; Nyo MY; Myint NZ; Imwong M; Ashley E; Lee SJ; White NJ Lancet Infect Dis; 2010 Oct; 10(10):673-81. PubMed ID: 20832366 [TBL] [Abstract][Full Text] [Related]
22. A single low dose of primaquine is safe and sufficient to reduce transmission of Plasmodium falciparum gametocytes regardless of cytochrome P450 2D6 enzyme activity in Bagamoyo district, Tanzania. Mwaiswelo RO; Ngasala B; Msolo D; Kweka E; Mmbando BP; Mårtensson A Malar J; 2022 Mar; 21(1):84. PubMed ID: 35279143 [TBL] [Abstract][Full Text] [Related]
24. Single dose primaquine to reduce gametocyte carriage and Plasmodium falciparum transmission in Cambodia: An open-label randomized trial. Lin JT; Lon C; Spring MD; Sok S; Chann S; Ittiverakul M; Kuntawunginn W; My M; Thay K; Rahman R; Balasubramanian S; Char M; Lanteri CA; Gosi P; Ubalee R; Meshnick SR; Saunders DL PLoS One; 2017; 12(6):e0168702. PubMed ID: 28591198 [TBL] [Abstract][Full Text] [Related]
25. Primaquine clears submicroscopic Plasmodium falciparum gametocytes that persist after treatment with sulphadoxine-pyrimethamine and artesunate. Shekalaghe S; Drakeley C; Gosling R; Ndaro A; van Meegeren M; Enevold A; Alifrangis M; Mosha F; Sauerwein R; Bousema T PLoS One; 2007 Oct; 2(10):e1023. PubMed ID: 17925871 [TBL] [Abstract][Full Text] [Related]
26. Single Low Dose Primaquine (0.25 mg/kg) Does Not Cause Clinically Significant Haemolysis in G6PD Deficient Subjects. Bancone G; Chowwiwat N; Somsakchaicharoen R; Poodpanya L; Moo PK; Gornsawun G; Kajeechiwa L; Thwin MM; Rakthinthong S; Nosten S; Thinraow S; Nyo SN; Ling CL; Wiladphaingern J; Kiricharoen NL; Moore KA; White NJ; Nosten F PLoS One; 2016; 11(3):e0151898. PubMed ID: 27010542 [TBL] [Abstract][Full Text] [Related]
27. Adding a single low-dose of primaquine (0.25 mg/kg) to artemether-lumefantrine did not compromise treatment outcome of uncomplicated Plasmodium falciparum malaria in Tanzania: a randomized, single-blinded clinical trial. Mwaiswelo R; Ngasala B; Jovel I; Aydin-Schmidt B; Gosling R; Premji Z; Mmbando B; Björkman A; Mårtensson A Malar J; 2016 Aug; 15(1):435. PubMed ID: 27565897 [TBL] [Abstract][Full Text] [Related]
28. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas. Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557 [TBL] [Abstract][Full Text] [Related]
29. Safety of age-dosed, single low-dose primaquine in children with glucose-6-phosphate dehydrogenase deficiency who are infected with Plasmodium falciparum in Uganda and the Democratic Republic of the Congo: a randomised, double-blind, placebo-controlled, non-inferiority trial. Taylor WR; Olupot-Olupot P; Onyamboko MA; Peerawaranun P; Weere W; Namayanja C; Onyas P; Titin H; Baseke J; Muhindo R; Kayembe DK; Ndjowo PO; Basara BB; Bongo GS; Okalebo CB; Abongo G; Uyoga S; Williams TN; Taya C; Dhorda M; Tarning J; Dondorp AM; Waithira N; Fanello C; Maitland K; Mukaka M; Day NJP Lancet Infect Dis; 2023 Apr; 23(4):471-483. PubMed ID: 36462528 [TBL] [Abstract][Full Text] [Related]
30. Pyronaridine-artesunate or dihydroartemisinin-piperaquine combined with single low-dose primaquine to prevent Stone W; Mahamar A; Sanogo K; Sinaba Y; Niambele SM; Sacko A; Keita S; Youssouf A; Diallo M; Soumare HM; Kaur H; Lanke K; Ter Heine R; Bradley J; Issiaka D; Diawara H; Traore SF; Bousema T; Drakeley C; Dicko A Lancet Microbe; 2022 Jan; 3(1):e41-e51. PubMed ID: 35028628 [TBL] [Abstract][Full Text] [Related]
31. An optimised age-based dosing regimen for single low-dose primaquine for blocking malaria transmission in Cambodia. Leang R; Khu NH; Mukaka M; Debackere M; Tripura R; Kheang ST; Chy S; Kak N; Buchy P; Tarantola A; Menard D; Roca-Felterer A; Fairhurst RM; Kheng S; Muth S; Ngak S; Dondorp AM; White NJ; Taylor WR BMC Med; 2016 Oct; 14(1):171. PubMed ID: 27784313 [TBL] [Abstract][Full Text] [Related]
32. Randomized, multicentre assessment of the efficacy and safety of ASAQ--a fixed-dose artesunate-amodiaquine combination therapy in the treatment of uncomplicated Plasmodium falciparum malaria. Ndiaye JL; Randrianarivelojosia M; Sagara I; Brasseur P; Ndiaye I; Faye B; Randrianasolo L; Ratsimbasoa A; Forlemu D; Moor VA; Traore A; Dicko Y; Dara N; Lameyre V; Diallo M; Djimde A; Same-Ekobo A; Gaye O Malar J; 2009 Jun; 8():125. PubMed ID: 19505304 [TBL] [Abstract][Full Text] [Related]
33. Nonrandomized controlled trial of artesunate plus sulfadoxine-pyrimethamine with or without primaquine for preventing posttreatment circulation of Plasmodium falciparum gametocytes. Shah NK; Schapira A; Juliano JJ; Srivastava B; MacDonald PD; Poole C; Anvikar A; Meshnick SR; Valecha N; Mishra N Antimicrob Agents Chemother; 2013 Jul; 57(7):2948-54. PubMed ID: 23587943 [TBL] [Abstract][Full Text] [Related]
34. Safety and tolerability of single low-dose primaquine in a low-intensity transmission area in South Africa: an open-label, randomized controlled trial. Raman J; Allen E; Workman L; Mabuza A; Swanepoel H; Malatje G; Frean J; Wiesner L; Barnes KI Malar J; 2019 Jun; 18(1):209. PubMed ID: 31234865 [TBL] [Abstract][Full Text] [Related]
35. [Therapeutic efficacy of a regimen of artesunate-mefloquine-primaquine treatment for Plasmodium falciparum malaria and treatment effects on gametocytic development]. Vásquez AM; Sanín F; Alvarez LG; Tobón A; Ríos A; Blair S Biomedica; 2009 Jun; 29(2):307-19. PubMed ID: 20128355 [TBL] [Abstract][Full Text] [Related]
36. Understanding human genetic factors influencing primaquine safety and efficacy to guide primaquine roll-out in a pre-elimination setting in southern Africa. Awandu SS; Raman J; Makhanthisa TI; Kruger P; Frean J; Bousema T; Niemand J; Birkholtz LM Malar J; 2018 Mar; 17(1):120. PubMed ID: 29558929 [TBL] [Abstract][Full Text] [Related]
37. Defining Plasmodium falciparum treatment in South West Asia: a randomized trial comparing artesunate or primaquine combined with chloroquine or SP. Kolaczinski K; Leslie T; Ali I; Durrani N; Lee S; Barends M; Beshir K; Ord R; Hallett R; Rowland M PLoS One; 2012; 7(1):e28957. PubMed ID: 22303437 [TBL] [Abstract][Full Text] [Related]
38. In vivo/ex vivo efficacy of artemether-lumefantrine and artesunate-amodiaquine as first-line treatment for uncomplicated falciparum malaria in children: an open label randomized controlled trial in Burkina Faso. Lingani M; Bonkian LN; Yerbanga I; Kazienga A; Valéa I; Sorgho H; Ouédraogo JB; Mens PF; Schallig HDFH; Ravinetto R; d'Alessandro U; Tinto H Malar J; 2020 Jan; 19(1):8. PubMed ID: 31906948 [TBL] [Abstract][Full Text] [Related]
39. Single dose primaquine for clearance of Plasmodium falciparum gametocytes in children with uncomplicated malaria in Uganda: a randomised, controlled, double-blind, dose-ranging trial. Eziefula AC; Bousema T; Yeung S; Kamya M; Owaraganise A; Gabagaya G; Bradley J; Grignard L; Lanke KH; Wanzira H; Mpimbaza A; Nsobya S; White NJ; Webb EL; Staedke SG; Drakeley C Lancet Infect Dis; 2014 Feb; 14(2):130-9. PubMed ID: 24239324 [TBL] [Abstract][Full Text] [Related]
40. Safety and Efficacy of Adding a Single Low Dose of Primaquine to the Treatment of Adult Patients With Plasmodium falciparum Malaria in Senegal, to Reduce Gametocyte Carriage: A Randomized Controlled Trial. Tine RC; Sylla K; Faye BT; Poirot E; Fall FB; Sow D; Wang D; Ndiaye M; Ndiaye JL; Faye B; Greenwood B; Gaye O; Milligan P Clin Infect Dis; 2017 Aug; 65(4):535-543. PubMed ID: 28605472 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]